Rogrand

Rogrand is a private Chinese healthtech company that operates a pharmaceutical industry-chain service platform rather than a therapeutic drug-development business. Founded in 2012 and headquartered in Beijing, the company provides third-party pharmaceutical supply chain trading, e-commerce, smart clinic and health-management tools, and related digital services intended to connect manufacturers, distributors, pharmacies, clinics, and medical institutions. Its business model appears focused on improving circulation, marketing efficiency, drug information services, and online healthcare-related workflows across China’s pharmaceutical ecosystem. Available sources indicate the company is active, venture-backed, and generating revenue, with funding rounds reported through Series E. Rogrand does not appear to have a disclosed biotech or pharma therapeutic pipeline in the conventional sense.